{"id":25890,"date":"2026-06-25T00:00:00","date_gmt":"2026-06-24T22:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=7af034961fe1fd00e2d8d88d972bb1cf"},"modified":"2026-06-25T00:00:00","modified_gmt":"2026-06-24T22:00:00","slug":"statement-from-the-board-of-brera-holdings-plc-solmate-2","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=25890","title":{"rendered":"Statement From the Board of Brera Holdings Plc (\u201cSolmate\u201d)"},"content":{"rendered":"

DUBLIN--(BUSINESS WIRE)--Solmate (Nasdaq: SLMT)<\/b><\/p><\/a><\/a>

\nIRISH TAKEOVER PANEL<\/b><\/p>

\nOPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE<\/b><\/p>

\n1. KEY INFORMATION<\/b><\/p>\n\n\n\n\n\n\n

\n(a) Full name of discloser:<\/b><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n

\n(b) Owner or controller of interests and short<\/b> positions disclosed, if different from 1(a):<\/b><\/p>

\n\u00a0<\/p>

\nThe naming of nominee or vehicle companies is<\/i> insufficient. For a trust, the trustee(s), settlor and<\/i> beneficiaries must be named.<\/i><\/p><\/td>

\nN\/A<\/b><\/p><\/td><\/tr>\n

\n(c) Name of offeror\/offeree in relation to whose<\/b> relevant securities this form relates:<\/b><\/p>

\n\u00a0<\/p>

\nUse a separate form for each offeror\/offeree<\/i><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n

\n(d) Is the discloser the offeror or the offeree?<\/b><\/p><\/td>

\nOFFEREE<\/b><\/p><\/td><\/tr>\n

\n(e) Date position held:<\/b><\/p>

\n\u00a0<\/p>

\nThe latest practicable date prior to the disclosure<\/i><\/p><\/td>

\n23 June 2026<\/p><\/td><\/tr>\n

\n(f) In addition to the company in 1(c) above, is the<\/b> discloser also making disclosures in respect<\/b> of any other party to the offer?<\/b><\/p>

\n\u00a0<\/p>

\nIf it is a cash offer or possible cash offer, state<\/i> \u201cN\/A\u201d<\/i><\/p><\/td>

\nNO<\/b><\/p><\/td><\/tr>\n<\/table>

\n2. INTERESTS AND SHORT POSITIONS<\/b><\/p>

\nIf there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.<\/i><\/p>

\nInterests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates <\/b>(Note 1)<\/p>\n\n\n\n\n\n\n\n

\nClass of relevant security: <\/b>(Note 2)<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nInterests<\/b><\/p><\/td>

\nShort positions<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nNumber<\/b><\/p><\/td>

\n%<\/b><\/p><\/td>

\nNumber<\/b><\/p><\/td>

\n%<\/b><\/p><\/td><\/tr>\n

\n(1) Relevant securities owned<\/b> and\/or controlled:<\/b><\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td><\/tr>\n

\n(2) Cash-settled derivatives:<\/b><\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td><\/tr>\n

\n(3) Stock-settled derivatives<\/b> (including options) and<\/b> agreements to purchase\/<\/b> sell:<\/b><\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td><\/tr>\n

\nTotal:<\/b><\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td>

\nNil<\/p><\/td>

\n-<\/p><\/td><\/tr>\n<\/table>

\nAll interests and all short positions should be disclosed.<\/i><\/p>

\nDetails of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.<\/i><\/p>

\n3. INTERESTS AND SHORT POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY MAKING THE DISCLOSURE<\/b><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Details of any interests and short positions (including directors\u2019<\/b> and other employee options) of any person acting in concert with<\/b> the party making the disclosure:<\/b><\/td>\n<\/tr>\n
\n\n\n\n\u00a0<\/td>\n<\/tr>\n

\nBrera Holdings Plc Directors:<\/b> The directors of Brera Holdings Plc detailed in the table below (together with their connected persons under Rule 3.3(b)(ii) of Part A of the Irish Takeover Rules) have the following interests in the relevant securities of Brera Holdings Plc.<\/i><\/p><\/td>

\nClass of Relevant Security<\/b><\/p><\/td>

\nNumber of ordinary shares held at midnight on 23 June 2026<\/b><\/p><\/td>

\nPercentage of issued share capital<\/b><\/p><\/td>

\nTotal number of ordinary shares underlying<\/b><\/p>

\nunexercised warrants,<\/b><\/p>

\nrestricted stock units (\u201cRSUs\u201d),<\/b><\/p>

\nand other<\/b><\/p>

\nsubscription<\/b><\/p>

\nrights.<\/b><\/p><\/td><\/tr>\n

\n\n\n\n\u00a0<\/td>\n<\/tr>\n

\nAlyazi Saeed Ahmad Alkhattal Almheiri<\/b><\/p><\/td>

\nClass B Ordinary Shares<\/p><\/td>

\n174,983<\/p><\/td>

\n1.59%<\/p><\/td>

\n87,777<\/p><\/td><\/tr>\n

\n\n\n\n\u00a0<\/td>\n<\/tr>\n

\nErez Simha<\/b><\/p><\/td>

\nClass B Ordinary Shares<\/p><\/td>

\n0<\/p><\/td>

\n0%<\/p><\/td>

\n25,981<\/p><\/td><\/tr>\n

\n\n\n\n\u00a0<\/td>\n<\/tr>\n

\nKeren Maimon<\/b><\/p><\/td>

\nClass B Ordinary Shares<\/p><\/td>

\n1,336,330<\/p><\/td>

\n12.12%<\/p><\/td>

\n101,110<\/p><\/td><\/tr>\n

\n\n\n\n\u00a0<\/td>\n<\/tr>\n

\nRon Sade<\/b><\/p><\/td>

\nClass B Ordinary Shares<\/p><\/td>

\n1,338,978<\/p><\/td>

\n12.14%<\/p><\/td>

\n104,888<\/p><\/td><\/tr>\n

\n\n\n\n\u00a0<\/td>\n<\/tr>\n

\nTariq Salem Ebraheem Alsaman Alnuaimi<\/b><\/p><\/td>

\nClass B Ordinary Shares<\/p><\/td>

\n349,974<\/p><\/td>

\n3.17%<\/p><\/td>

\n171,110<\/p><\/td><\/tr>\n<\/table>

\nDetails of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.<\/i><\/p>

\n4. OTHER INFORMATION<\/b><\/p>

\n(a) Indemnity and other dealing arrangements<\/b><\/p>\n\n\n\n\n

\nDetails of any indemnity or option arrangement, or any agreement<\/b> or understanding, formal or informal, relating to relevant securities<\/b> which may be an inducement to deal or refrain from dealing<\/b> entered into by the party to the offer making the disclosure or any<\/b> person acting in concert with it:<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td><\/tr>\n

\nIrrevocable commitments and letters of intent should not be included. If<\/i> there are no such agreements, arrangements or understandings, state<\/i> \u201cnone\u201d<\/i><\/p><\/td><\/tr>\n

\n\u00a0<\/p>

\n\u00a0<\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(b) Agreements, arrangements or understandings relating to options or derivatives<\/b><\/p>\n\n\n

\nFull details of any agreement, arrangement or understanding<\/b> between the person disclosing and any other person relating<\/b> to the voting rights of any relevant securities under any option<\/b> referred to on this form or relating to the voting rights or future<\/b> acquisition or disposal of any relevant securities to which any<\/b> derivative referred to on this form is referenced. If none, this<\/b> should be stated.<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p>

\n\u00a0<\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(c) Attachments<\/b><\/p>\n\n\n

\nIs a Supplemental Form 8 attached?<\/b><\/p><\/td>

\nYES\/NO<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p>

\n\u00a0<\/p>

\n\u00a0<\/p><\/td>

\nNO<\/b><\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>\n\n\n\n

\nDate of disclosure:<\/b><\/p><\/td>

\n24 June 2026<\/p><\/td><\/tr>\n

\nContact name:<\/b><\/p><\/td>

\nRon Sade<\/p><\/td><\/tr>\n

\nTelephone number:<\/b><\/p><\/td>

\n+1 253-271-9108<\/p><\/td><\/tr>\n<\/table>

\nPublic disclosures under Rule 8.1 of the Rules must be made to a Regulatory Information Service.<\/i><\/p>

\nNOTES ON FORM 8.1(a) and (b)<\/i><\/p>

\n1. See the definition of \u201cinterest in a relevant security\u201d in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) of Part B of the Rules.<\/i><\/p>

\n2. See the definition of \u201crelevant securities\u201d in Rule 2.1 of Part A of the Rules.<\/i><\/p>

\n3. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.<\/i><\/p>

\nFor full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.<\/i><\/p>

\nReferences in these notes to \u201cthe Rules\u201d are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.<\/i><\/p>

\nFORM 8.3<\/b><\/p>

\nIRISH TAKEOVER PANEL<\/b><\/p>

\nOPENING POSITION DISCLOSURE\/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER<\/b><\/p>

\nRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE<\/b><\/p>

\n1. KEY INFORMATION<\/b><\/p>\n\n\n\n\n\n\n

\n(a) Full name of discloser<\/b><\/p><\/td>

\nErez Simha<\/p><\/td><\/tr>\n

\n(b) Owner or controller of interests and short<\/b> positions disclosed, if different from 1(a)<\/b><\/p>

\nThe naming of nominee or vehicle companies is<\/i> insufficient. For a trust, the trustee(s), settlor and<\/i> beneficiaries must be named.<\/i><\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(c) Name of offeror\/offeree in relation to whose<\/b> relevant securities this form relates<\/b><\/p>

\nUse a separate form for each offeror\/offeree<\/i><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n

\n(d) If an exempt fund manager connected with an<\/b> offeror\/offeree, state this and specify identity<\/b> of offeror\/offeree <\/b>(Note 1)<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(e) Date position held\/dealing undertaken<\/b><\/p>

\nFor an opening position disclosure, state the<\/i> latest practicable date prior to the disclosure<\/i><\/p><\/td>

\n23 June 2026<\/p><\/td><\/tr>\n

\n(f) In addition to the company in 1(c) above, is the<\/b> discloser also making disclosures in respect<\/b> of any other party to the offer?<\/b><\/p>

\nIf it is a cash offer or possible cash offer, state<\/i> \u201cN\/A\u201d<\/i><\/p><\/td>

\nNO<\/b><\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n2. INTERESTS AND SHORT POSITIONS<\/b><\/p>

\nIf there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.<\/i><\/p>

\nInterests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)<\/b><\/p>

\n(Note 2)<\/p>\n\n\n\n\n\n\n\n

\nClass of relevant security<\/b>(Note 3)<\/p><\/td>

\nClass B Ordinary Shares with nominal value $0.50 each<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nInterests<\/b><\/p><\/td>

\nShort positions<\/b><\/p><\/td><\/tr>\n

\nNumber<\/b><\/p><\/td>

\n%<\/b><\/p><\/td>

\nNumber<\/b><\/p><\/td>

\n%<\/b><\/p><\/td><\/tr>\n

\n(1) Relevant securities owned and\/or controlled<\/b><\/p><\/td>

\n3,248<\/p><\/td>

\n0.29%<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(2) Cash-settled derivatives<\/b><\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(3) Stock-settled derivatives<\/b> (including options) and<\/b> agreements to purchase\/<\/b> sell<\/b><\/p><\/td>

\n22,733<\/p><\/td>

\n0.21%<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nTotal<\/b><\/p><\/td>

\n25,981<\/p><\/td>

\n0.24%<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\nAll interests and all short positions should be disclosed.<\/i><\/p>

\nDetails of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.<\/i><\/p>

\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE <\/b>(Note 4)<\/p>

\nWhere there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.<\/i><\/p>

\nThe currency of all prices and other monetary amounts should be stated.<\/i><\/p>

\n(a) Purchases and sales<\/b><\/p>\n\n\n

\nClass of relevant\nsecurity<\/b><\/p><\/td>

\nPurchase\/sale<\/b><\/p><\/td>

\nNumber of\nsecurities<\/b><\/p><\/td>

\nPrice per unit\n<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(b) Cash-settled derivative transactions<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b>e.g. CFD<\/i><\/p><\/td>

\nNature of dealing<\/b>e.g. opening\/<\/i> closing a long\/<\/i> short position,<\/i> increasing\/ reducing a long\/ short position<\/i><\/p><\/td>

\nNumber of<\/b>reference<\/b>securities<\/b>(Note 6)<\/p><\/td>

\nPrice<\/b>per unit<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(c) Stock-settled derivative transactions (including options)<\/b><\/p>

\n(i) Writing, selling, purchasing or varying<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b> e.g. call<\/i>option<\/i><\/p><\/td>

\nWriting,<\/b> purchasing,<\/b> selling,<\/b> varying<\/b>etc.<\/b><\/p><\/td>

\nNumber<\/b>of<\/b>securities<\/b>to which<\/b>option<\/b>relates<\/b>(Note 6)<\/b><\/p><\/td>

\nExercise\nprice per<\/b>unit<\/b><\/p><\/td>

\nType<\/b>e.g.<\/i>American,<\/i>European\netc.<\/i><\/p><\/td>

\nExpiry<\/b>date<\/b><\/p><\/td>

\nOption<\/b>money\npaid\/<\/b>received<\/b> per unit<\/b><\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(ii) Exercise<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b>e.g. call<\/i>option<\/i><\/p><\/td>

\nExercising\/<\/b>exercised<\/b>against<\/b><\/p><\/td>

\nNumber of<\/b>securities<\/b><\/p><\/td>

\nExercise<\/b>price per<\/b>unit<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(d) Other dealings (including transactions in respect of new securities) <\/b>(Note 3)<\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nNature of dealing<\/b>e.g. subscription,<\/i>conversion, exercise<\/i><\/p><\/td>

\nDetails<\/b><\/p><\/td>

\nPrice per unit (if<\/b>applicable)<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n4. OTHER INFORMATION<\/b><\/p>

\n(a) Indemnity and other dealing arrangements<\/b><\/p>\n\n\n

\nDetails of any indemnity or option arrangement, or any agreement<\/b> or understanding, formal or informal, relating to relevant securities<\/b> which may be an inducement to deal or refrain from dealing<\/b> entered into by the person making the disclosure and any party to<\/b> the offer or any person acting in concert with a party to the offer.<\/b><\/p>

\nIrrevocable commitments and letters of intent should not be included. If<\/i> there are no such agreements, arrangements or understandings, state<\/i> \u201cnone\u201d<\/i><\/p><\/td><\/tr>\n

\nNone<\/p><\/td><\/tr>\n<\/table>

\n(b) Agreements, arrangements or understandings relating to options or derivatives<\/b><\/p>\n\n\n

\nFull details of any agreement, arrangement or understanding<\/b> between the person disclosing and any other person relating<\/b> to the voting rights of any relevant securities under any option<\/b> referred to on this form or relating to the voting rights or future<\/b> acquisition or disposal of any relevant securities to which any<\/b> derivative referred to on this form is referenced. If none, this<\/b> should be stated.<\/b><\/p><\/td><\/tr>\n

\nNone<\/p><\/td><\/tr>\n<\/table>

\n(c) Attachments<\/b><\/p>\n\n

\nIs a Supplemental Form 8 attached?<\/b><\/p><\/td>

\nYES<\/b><\/p><\/td><\/tr>\n<\/table>\n\n\n\n

\nDate of disclosure<\/b><\/p><\/td>

\n24 June 2026<\/p><\/td><\/tr>\n

\nContact name<\/b><\/p><\/td>

\nErez Simha<\/p><\/td><\/tr>\n

\nTelephone number<\/b><\/p><\/td>

\n+1 253-271-9108<\/p><\/td><\/tr>\n<\/table>

\nPublic disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.<\/i><\/p>

\nNOTES ON FORM 8.3<\/b><\/p>

\n1. See the definition of \u201cconnected fund manager\u201d in Rule 2.2 of Part A of the Rules.<\/i><\/b><\/p>

\n2. See the definition of \u201cinterest in a relevant security\u201d in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.<\/i><\/b><\/p>

\n3. See the definition of \u201crelevant securities\u201d in Rule 2.1 of Part A of the Rules.<\/i><\/b><\/p>

\n4. See the definition of \u201cdealing\u201d in Rule 2.1 of Part A of the Rules.<\/i><\/b><\/p>

\n5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.<\/i><\/b><\/p>

\n6. See Rule 2.5(d) of Part A of the Rules.<\/i><\/b><\/p>

\n7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.<\/i><\/b><\/p>

\nFor full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.<\/i><\/b><\/p>

\nReferences in these notes to \u201cthe Rules\u201d are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.<\/i><\/b><\/p>

\nSUPPLEMENTAL FORM 8<\/b><\/p>

\nIRISH TAKEOVER PANEL<\/b><\/p>

\nDISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND<\/b><\/p>

\nRULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,<\/b><\/p>

\nTAKEOVER RULES, 2022<\/b><\/p>

\nDETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING<\/b><\/p>

\nOPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND<\/b><\/p>

\nRIGHTS TO SUBSCRIBE FOR NEW SECURITIES<\/b><\/p>

\n1. KEY INFORMATION<\/b><\/p>\n\n\n

\nFull name of person making<\/b>disclosure:<\/b><\/p><\/td>

\nErez Simha<\/p><\/td><\/tr>\n

\nName of offeror\/offeree in relation<\/b>to whose relevant securities the<\/b>disclosure relates:<\/b><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n<\/table>

\n2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b>e.g. call<\/i>option<\/i><\/p><\/td>

\nWritten or<\/b>purchased<\/b><\/p><\/td>

\nNumber of<\/b>securities to\nwhich option\nor derivative<\/b>relates<\/b><\/p><\/td>

\nExercise<\/b>price<\/b>per unit<\/b><\/p><\/td>

\nType<\/b>e.g.<\/i>American,<\/i>European<\/i>etc.<\/i><\/p><\/td>

\nExpiry<\/b>date<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n3. AGREEMENTS TO PURCHASE OR SELL<\/b><\/p>\n\n\n

\nFull details should be given so that the nature of the interest or<\/b> position can be fully understood:<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS\u2019 AND OTHER EMPLOYEE OPTIONS)<\/b><\/p>\n\n\n

\nClass of relevant security in<\/b> relation to which subscription<\/b> right exists:<\/b><\/p><\/td>

\nClass B Ordinary Shares with nominal value $0.50 each<\/p><\/td><\/tr>\n

\nDetails, including nature of the<\/b> rights concerned and relevant<\/b> percentages:<\/b><\/p><\/td>

\nRestricted Stock Units (\u201cRSUs\u201d)1<\/sup><\/i><\/p>

\n\u00a0<\/p>

\nGrant Date\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Number of shares\u00a0\u00a0\u00a0\u00a0\u00a0Exercise Price\u00a0\u00a0\u00a0\u00a0\u00a0Expiry Date<\/p>

\n3 April 2026\u00a0\u00a0\u00a0\u00a0\u00a0\u00a022,733\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0$0.00\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0None<\/p>

\n\u00a0<\/p>

\n1<\/sup>RSUs Vesting Schedule<\/p>

\n1. 25,981 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant.<\/p>

\n2. To date, 3,248 units from the original grant of RSUs have vested, leaving 22,733 granted but unvested.<\/p>

\n3. When all remaining RSUs vest, it will result in an increased interest of 0.21%.<\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\nIt is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.<\/i><\/p>

\nThe currency of all prices and other monetary amounts should be stated.<\/i><\/p>

\nFor full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.<\/i><\/b><\/p>

\nReferences in these notes to \u201cthe Rules\u201d are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.<\/i><\/b><\/p>

\nFORM 8.3<\/b><\/p>

\nIRISH TAKEOVER PANEL<\/b><\/p>

\nOPENING POSITION DISCLOSURE\/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER<\/b><\/p>

\nRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE<\/b><\/p>

\n1. KEY INFORMATION<\/b><\/p>\n\n\n\n\n\n\n

\n(a) Full name of discloser<\/b><\/p><\/td>

\nAlyazi Saeed Ahmad Alkhattal Almheiri<\/p><\/td><\/tr>\n

\n(b) Owner or controller of interests and short<\/b> positions disclosed, if different from 1(a)<\/b><\/p>

\nThe naming of nominee or vehicle companies is<\/i> insufficient. For a trust, the trustee(s), settlor and<\/i> beneficiaries must be named.<\/i><\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(c) Name of offeror\/offeree in relation to whose<\/b> relevant securities this form relates<\/b><\/p>

\nUse a separate form for each offeror\/offeree<\/i><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n

\n(d) If an exempt fund manager connected with an<\/b> offeror\/offeree, state this and specify identity<\/b> of offeror\/offeree <\/b>(Note 1)<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(e) Date position held\/dealing undertaken<\/b><\/p>

\nFor an opening position disclosure, state the<\/i> latest practicable date prior to the disclosure<\/i><\/p><\/td>

\n23 June 2026<\/p><\/td><\/tr>\n

\n(f) In addition to the company in 1(c) above, is the<\/b> discloser also making disclosures in respect<\/b> of any other party to the offer?<\/b><\/p>

\nIf it is a cash offer or possible cash offer, state<\/i> \u201cN\/A\u201d<\/i><\/p><\/td>

\nNO<\/p><\/td><\/tr>\n<\/table>

\n2. INTERESTS AND SHORT POSITIONS<\/b><\/p>

\nIf there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.<\/i><\/p>

\nInterests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)<\/b><\/p>

\n(Note 2)<\/p>\n\n\n\n\n\n\n\n

\nClass of relevant security<\/b>(Note 3)<\/p><\/td>

\nClass B Ordinary Shares with nominal value $0.50 each<\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\nInterests<\/b><\/p><\/td>

\nShort positions<\/b><\/p><\/td><\/tr>\n

\nNumber<\/b><\/p><\/td>

\n%<\/b><\/p><\/td>

\nNumber<\/b><\/p><\/td>

\n%<\/b><\/p><\/td><\/tr>\n

\n(1) Relevant securities owned and\/or controlled<\/b><\/p><\/td>

\n176,650<\/p><\/td>

\n1.60%<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(2) Cash-settled derivatives<\/b><\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(3) Stock-settled derivatives<\/b> (including options) and<\/b> agreements to purchase\/<\/b> sell<\/b><\/p><\/td>

\n86,110<\/p><\/td>

\n0.78%<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\nTotal<\/b><\/p><\/td>

\n262,760<\/p><\/td>

\n2.38%<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\nAll interests and all short positions should be disclosed.<\/i><\/p>

\nDetails of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.<\/i><\/p>

\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE <\/b>(Note 4)<\/p>

\nWhere there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.<\/i><\/p>

\nThe currency of all prices and other monetary amounts should be stated.<\/i><\/p>

\n(a) Purchases and sales<\/b><\/p>\n\n\n

\nClass of relevant\nsecurity<\/b><\/p><\/td>

\nPurchase\/sale<\/b><\/p><\/td>

\nNumber of\nsecurities<\/b><\/p><\/td>

\nPrice per unit\n<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(b) Cash-settled derivative transactions<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b>e.g. CFD<\/i><\/p><\/td>

\nNature of dealing<\/b>e.g. opening\/<\/i> closing a long\/<\/i> short position,<\/i> increasing\/ reducing a long\/ short position<\/i><\/p><\/td>

\nNumber of<\/b>reference<\/b>securities<\/b>(Note 6)<\/p><\/td>

\nPrice<\/b>per unit<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(c) Stock-settled derivative transactions (including options)<\/b><\/p>

\n(i) Writing, selling, purchasing or varying<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b> e.g. call<\/i>option<\/i><\/p><\/td>

\nWriting,<\/b> purchasing,<\/b> selling,<\/b> varying<\/b>etc.<\/b><\/p><\/td>

\nNumber<\/b>of<\/b>securities<\/b>to which<\/b>option<\/b>relates<\/b>(Note 6)<\/b><\/p><\/td>

\nExercise\nprice per<\/b>unit<\/b><\/p><\/td>

\nType<\/b>e.g.<\/i>American,<\/i>European\netc.<\/i><\/p><\/td>

\nExpiry<\/b>date<\/b><\/p><\/td>

\nOption<\/b>money\npaid\/<\/b>received<\/b> per unit<\/b><\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(ii) Exercise<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b>e.g. call<\/i>option<\/i><\/p><\/td>

\nExercising\/<\/b>exercised<\/b>against<\/b><\/p><\/td>

\nNumber of<\/b>securities<\/b><\/p><\/td>

\nExercise<\/b>price per<\/b>unit<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n(d) Other dealings (including transactions in respect of new securities) <\/b>(Note 3)<\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nNature of dealing<\/b>e.g. subscription,<\/i>conversion, exercise<\/i><\/p><\/td>

\nDetails<\/b><\/p><\/td>

\nPrice per unit (if<\/b>applicable)<\/b>(Note 5)<\/p><\/td><\/tr>\n

\nN\/A<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n4. OTHER INFORMATION<\/b><\/p>

\n(a) Indemnity and other dealing arrangements<\/b><\/p>\n\n\n

\nDetails of any indemnity or option arrangement, or any agreement<\/b> or understanding, formal or informal, relating to relevant securities<\/b> which may be an inducement to deal or refrain from dealing<\/b> entered into by the person making the disclosure and any party to<\/b> the offer or any person acting in concert with a party to the offer.<\/b><\/p>

\nIrrevocable commitments and letters of intent should not be included. If<\/i> there are no such agreements, arrangements or understandings, state<\/i> \u201cnone\u201d<\/i><\/p><\/td><\/tr>\n

\nNone<\/p><\/td><\/tr>\n<\/table>

\n(b)<\/b> Agreements, arrangements or understandings relating to options or derivatives<\/b><\/p>\n\n\n

\nFull details of any agreement, arrangement or understanding<\/b> between the person disclosing and any other person relating<\/b> to the voting rights of any relevant securities under any option<\/b> referred to on this form or relating to the voting rights or future<\/b> acquisition or disposal of any relevant securities to which any<\/b> derivative referred to on this form is referenced. If none, this<\/b> should be stated.<\/b><\/p><\/td><\/tr>\n

\nNone<\/p><\/td><\/tr>\n<\/table>

\n(c) Attachments<\/b><\/p>\n\n

\nIs a Supplemental Form 8 attached?<\/b><\/p><\/td>

\nYES<\/b><\/p><\/td><\/tr>\n<\/table>\n\n\n\n

\nDate of disclosure<\/b><\/p><\/td>

\n24 June 2026<\/p><\/td><\/tr>\n

\nContact name<\/b><\/p><\/td>

\nAlyazi Saeed Ahmad Alkhattal Almheiri<\/p><\/td><\/tr>\n

\nTelephone number<\/b><\/p><\/td>

\n+1 253-271-9108<\/p><\/td><\/tr>\n<\/table>

\nPublic disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.<\/i><\/p>

\nNOTES ON FORM 8.3<\/b><\/p>

\n1. See the definition of \u201cconnected fund manager\u201d in Rule 2.2 of Part A of the Rules.<\/i><\/b><\/p>

\n2. See the definition of \u201cinterest in a relevant security\u201d in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.<\/i><\/b><\/p>

\n3. See the definition of \u201crelevant securities\u201d in Rule 2.1 of Part A of the Rules.<\/i><\/b><\/p>

\n4. See the definition of \u201cdealing\u201d in Rule 2.1 of Part A of the Rules.<\/i><\/b><\/p>

\n5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.<\/i><\/b><\/p>

\n6. See Rule 2.5(d) of Part A of the Rules.<\/i><\/b><\/p>

\n7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.<\/i><\/b><\/p>

\nFor full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.<\/i><\/b><\/p>

\nReferences in these notes to \u201cthe Rules\u201d are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.<\/i><\/b><\/p>

\nSUPPLEMENTAL FORM 8<\/b><\/p>

\nIRISH TAKEOVER PANEL<\/b><\/p>

\nDISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND<\/b><\/p>

\nRULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,<\/b><\/p>

\nTAKEOVER RULES, 2022<\/b><\/p>

\nDETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING<\/b><\/p>

\nOPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND<\/b><\/p>

\nRIGHTS TO SUBSCRIBE FOR NEW SECURITIES<\/b><\/p>

\n1. KEY INFORMATION<\/b><\/p>\n\n\n

\nFull name of person making<\/b>disclosure:<\/b><\/p><\/td>

\nAlyazi Saeed Ahmad Alkhattal Almheiri<\/p><\/td><\/tr>\n

\nName of offeror\/offeree in relation<\/b>to whose relevant securities the<\/b>disclosure relates:<\/b><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n<\/table>

\n2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)<\/b><\/p>\n\n\n

\nClass of<\/b>relevant<\/b>security<\/b><\/p><\/td>

\nProduct<\/b>description<\/b>e.g. call<\/i>option<\/i><\/p><\/td>

\nWritten or<\/b>purchased<\/b><\/p><\/td>

\nNumber of<\/b>securities to\nwhich option\nor derivative<\/b>relates<\/b><\/p><\/td>

\nExercise<\/b>price<\/b>per unit<\/b><\/p><\/td>

\nType<\/b>e.g.<\/i>American,<\/i>European<\/i>etc.<\/i><\/p><\/td>

\nExpiry<\/b>date<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n3. AGREEMENTS TO PURCHASE OR SELL<\/b><\/p>\n\n\n

\nFull details should be given so that the nature of the interest or<\/b> position can be fully understood:<\/b><\/p><\/td><\/tr>\n

\n\u00a0<\/p><\/td><\/tr>\n<\/table>

\n4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS\u2019 AND OTHER EMPLOYEE OPTIONS)<\/b><\/p>\n\n\n

\nClass of relevant security in<\/b> relation to which subscription<\/b> right exists:<\/b><\/p><\/td>

\nClass B Ordinary Shares with nominal value $0.50 each<\/p><\/td><\/tr>\n

\nDetails, including nature of the<\/b> rights concerned and relevant<\/b> percentages:<\/b><\/p><\/td>

\n(a) Restricted Stock Units (\u201cRSUs\u201d)1<\/sup><\/i><\/p>

\n\u00a0<\/p>

\nGrant Date\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Number of shares\u00a0\u00a0\u00a0Exercise Price\u00a0\u00a0\u00a0\u00a0\u00a0Expiry Date<\/p>

\n23 September 2025 \u00a0\u00a0\u00a0\u00a02,777 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0$0.00\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a023 October 2027<\/p>

\n\u00a0<\/p>

\n1<\/sup>RSUs Vesting Schedule<\/p>

\n1. 4,444 RSUs were granted on the grant date, and the RSUs vest in substantially equal quarterly installments over a two-year period commencing from the date of the grant.<\/p>

\n2. To date, 1,667 units from the original grant of RSUs have vested, leaving 2,777 granted but unvested.<\/p>

\n3. When all remaining RSUs vest, it will result in an increased interest of 0.25%.<\/p>

\n\u00a0<\/p>

\n(b) Outstanding warrants \/ rights to subscribe for Class B Ordinary shares<\/i><\/p>

\n\u00a0<\/p>

\nGrant Date\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Number of shares\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Exercise Price\u00a0\u00a0\u00a0\u00a0\u00a0Expiry Date<\/p>

\n22 September 2025\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a055,555\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0$0.50\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0None<\/p>

\n22 September 2025\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a027,778\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0$67.50\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a022 September 2030<\/p>

\n1. If exercised, this would result in an increased interest of 0.5%.<\/p><\/td><\/tr>\n<\/table>

\nIt is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.<\/i><\/p>

\nThe currency of all prices and other monetary amounts should be stated.<\/i><\/p>

\nFor full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.<\/i><\/b><\/p>

\nReferences in these notes to \u201cthe Rules\u201d are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.<\/i><\/b><\/p>

\nFORM 8.3<\/b><\/p>

\nIRISH TAKEOVER PANEL<\/b><\/p>

\nOPENING POSITION DISCLOSURE\/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER<\/b><\/p>

\nRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE<\/b><\/p>

\n1. KEY INFORMATION<\/b><\/p>\n\n\n\n\n\n\n

\n(a) Full name of discloser<\/b><\/p><\/td>

\nTariq Salem Ebraheem Alsaman Alnuaimi<\/p><\/td><\/tr>\n

\n(b) Owner or controller of interests and short<\/b> positions disclosed, if different from 1(a)<\/b><\/p>

\nThe naming of nominee or vehicle companies is<\/i> insufficient. For a trust, the trustee(s), settlor and<\/i> beneficiaries must be named.<\/i><\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(c) Name of offeror\/offeree in relation to whose<\/b> relevant securities this form relates<\/b><\/p>

\nUse a separate form for each offeror\/offeree<\/i><\/p><\/td>

\nBrera Holdings Plc<\/p><\/td><\/tr>\n

\n(d) If an exempt fund manager connected with an<\/b> offeror\/offeree, state this and specify identity<\/b> of offeror\/offeree <\/b>(Note 1)<\/p><\/td>

\n\u00a0<\/p><\/td><\/tr>\n

\n(e) Date position held\/dealing undertaken<\/b><\/p>

\nFor an opening position disclosure, state the<\/i> latest practicable date prior to the disclosure<\/i><\/p><\/td>

\n23 June 2026<\/p><\/td><\/tr>\n

\n(f) In addition to the company in 1(c) above, is the<\/b> discloser also making disclosures in respect<\/b> of any other party to the offer?<\/b><\/p>

\nIf it is a cash offer or possible cash offer, state<\/i> \u201cN\/A\u201d<\/i><\/p><\/td>

\nNO<\/b><\/p><\/td><\/tr>\n<\/table> Contacts<\/b>

\nEnquiries:\nSolmate\nAlex Corp\nWachsman\nalex.corp@wachsman.com<\/a><\/p> Read full story here <\/a>","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–Solmate (Nasdaq: SLMT)
\nIRISH TAKEOVER PANEL
\nOPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE
\n1. KEY INFORMATION<\/p>\n

(a) Full name of dis…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-25890","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/25890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25890"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/25890\/revisions"}],"predecessor-version":[{"id":25891,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/25890\/revisions\/25891"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=25890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=25890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}